Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2026 for BXP, Inc. (BXP) and Boston Properties Limited Partnership (BPLP). BXP is a fully integrated, self-administered REIT that owns, develops, and manages premier office, retail, residential, and hotel properties in six gateway U.S. markets. As of March 31, 2026, the portfolio consisted of 164 properties aggregating approximately 50.4 million rentable square feet. BXP owns approximately 89.4% of BPLP, the operating partnership that holds substantially all assets.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenue | $872.1 million | $865.2 million |
| Net Income (Consolidated) | $133.0 million | $86.9 million |
| Net Income Attributable to BXP | $101.6 million | $61.2 million |
| Earnings Per Share (Diluted) | $0.64 | $0.39 |
| Funds from Operations (FFO) Attributable to BXP | $252.2 million | $260.6 million |
| Net Operating Income (NOI) | $506.0 million | $511.8 million |
| Net Cash Provided by Operating Activities | $156.5 million | $210.0 million |
| Total Consolidated Debt | $15.6 billion | $15.7 billion |
| Cash and Cash Equivalents | $512.8 million | $398.1 million |
| Weighted Average Occupancy | 87.4% | 86.7% |
Material Changes vs. Prior Period
- Profitability Surge: Net income attributable to BXP increased 66% to $101.6 million, driven primarily by a $41.2 million gain on the sale of unconsolidated joint venture interests (Gateway Commons and 7750 Wisconsin Avenue) and a $13.4 million gain on real estate sales.
- NOI Decline: Consolidated NOI decreased 1.1% to $506.0 million. This was due to the disposition of properties (reducing revenue base) and a decrease in hotel NOI, partially offset by growth in the Same Property Portfolio lease revenue.
- Debt Reduction: The company repaid $1.0 billion in aggregate principal of 3.650% senior notes due February 2026. Total consolidated debt decreased slightly to $15.6 billion.
- Asset Sales: The company completed sales of North First Business Park, Shady Grove Parcel 1, The Lofts at Atlantic Wharf, and its interests in Gateway Commons and 7750 Wisconsin Avenue, generating approximately $339.0 million in net proceeds.
- Leasing Momentum: Executed 68 leases totaling over 1.1 million square feet. Total portfolio leased percentage increased to 90.9%.
Outlook, Risks, and Management Commentary
- Strategic Execution: Management continues to execute a multi-year strategic plan focused on earnings growth through increased occupancy and development deliveries, alongside leverage reduction via asset sales. Approximately $1.2 billion in net proceeds from asset sales were generated through May 1, 2026.
- Development Pipeline: Six properties are under development or redevelopment with an estimated total investment of $3.7 billion. The commercial space in the pipeline was 61% pre-leased as of May 1, 2026. Key projects include 343 Madison Avenue (NYC) and 290 Binney Street (Cambridge, MA), the latter being 100% pre-leased to AstraZeneca.
- Legal Contingencies:
- NYC Property Acquisition: A dispute regarding "Additional" and "Final Fees" from a 2010 acquisition is pending a Special Referee's determination. Potential liability could theoretically reach $25 million plus interest, though the company disputes the calculations.
- Brammer Bio Litigation: A neighbor to the 290 Binney Street development has sued regarding construction impacts. An appeal hearing is anticipated in Q2 2026. An injunction could delay delivery to AstraZeneca, potentially triggering financial penalties.
- NYC Police Detail Program: The company is a defendant in a wage and hour class action lawsuit; discovery has not commenced, and loss is currently unestimable.
- Market Risks: Risks include volatile interest rates, geopolitical conflicts, supply chain disruptions, and the general risks affecting the office sector, including client preferences and space utilization.
Investor Verification Checklist
- Gain Sustainability: Verify the extent to which Q1 2026 net income growth is driven by one-time gains on asset sales ($54.7 million total) versus recurring operational performance.
- NOI Trends: Analyze the 1.1% decline in NOI and the specific impact of property dispositions on future revenue streams.
- Debt Maturity Wall: Confirm refinancing plans for the $1.0 billion of 2.750% unsecured senior notes maturing October 1, 2026, and the $100 million unsecured term loan maturing September 26, 2026.
- Development Capital Calls: Assess the $2.3 billion remaining estimated future equity requirement for development projects and the company's liquidity to fund these without dilutive equity issuance.
- Legal Exposure: Monitor the outcome of the Brammer Bio litigation and the NYC property fee dispute for potential material financial impact.